These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1521458)

  • 1. Treatment of gram-negative septic shock with an immunoglobulin.
    Werdan K; Pilz G
    Crit Care Med; 1992 Sep; 20(9):1364-5. PubMed ID: 1521458
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial.
    Wortel CH; Dellinger RP
    Crit Care Med; 1993 Jan; 21(1):163-5. PubMed ID: 8420724
    [No Abstract]   [Full Text] [Related]  

  • 3. Polymyxin B hemoperfusion and mortality in abdominal septic shock.
    Kida Y
    JAMA; 2009 Nov; 302(18):1969; author reply 1969-70. PubMed ID: 19903916
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to tumour necrosis factor in the treatment of severe sepsis: rationale and early clinical experience.
    Cohen J
    Prog Clin Biol Res; 1991; 367():187-96. PubMed ID: 1924427
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival in selected patients with gram-negative sepsis after adjunctive therapy with HA-1A.
    van Dissel JT; van Furth R; Compier BA; Feuth HD; Frolich M
    Lancet; 1993 Apr; 341(8850):959-60. PubMed ID: 8096292
    [No Abstract]   [Full Text] [Related]  

  • 6. Passive immunotherapy of gram-negative bacteremia, sepsis and septic shock.
    Spapen HD; Diltoer M; Huyghens LP
    Acta Clin Belg; 1993; 48(1):20-9. PubMed ID: 7684546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possibilities of immunoprophylaxis and immunotherapy in gut-derived infectious-toxic shock (GITS).
    Imbach P; Hässig A; Cottier H
    Curr Stud Hematol Blood Transfus; 1992; (59):301-23. PubMed ID: 1572217
    [No Abstract]   [Full Text] [Related]  

  • 9. New strategies in nonantibiotic treatment of gram-negative sepsis.
    Cohn J; Bone RC
    Cleve Clin J Med; 1992; 59(6):608-15. PubMed ID: 1424072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies for septic shock: in or out of the barn door?
    Nash DB; Johnson NE; Gottlieb JE; Vlasses PH
    QRB Qual Rev Bull; 1991 Oct; 17(10):310-3. PubMed ID: 1745528
    [No Abstract]   [Full Text] [Related]  

  • 11. [Monoclonal antibodies in the treatment of septic shock].
    Trilla A; Alonso P
    Med Clin (Barc); 1992 Dec; 99(20):778-80. PubMed ID: 1460950
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial.
    Schedel I; Dreikhausen U; Nentwig B; Höckenschnieder M; Rauthmann D; Balikcioglu S; Coldewey R; Deicher H
    Crit Care Med; 1991 Sep; 19(9):1104-13. PubMed ID: 1884609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct hemoperfusion with a polymyxin B column versus vasopressin for gram negative septic shock: a matched cohort study of the effect on survival.
    Sawa N; Ubara Y; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hoshino J; Suwabe T; Uchida N; Wake A; Taniguchi S; Takaichi K
    Clin Nephrol; 2013 Jun; 79(6):463-70. PubMed ID: 23253903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxin-based molecular strategies for the prevention and treatment of gram-negative sepsis and septic shock.
    Pollack M; Ohl CA
    Curr Top Microbiol Immunol; 1996; 216():275-97. PubMed ID: 8791745
    [No Abstract]   [Full Text] [Related]  

  • 15. Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected gram-negative sepsis.
    Balogun RA
    Crit Care Med; 2005 Feb; 33(2):461-2. PubMed ID: 15699862
    [No Abstract]   [Full Text] [Related]  

  • 16. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
    Cruz DN; Antonelli M; Fumagalli R; Foltran F; Brienza N; Donati A; Malcangi V; Petrini F; Volta G; Bobbio Pallavicini FM; Rottoli F; Giunta F; Ronco C
    JAMA; 2009 Jun; 301(23):2445-52. PubMed ID: 19531784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human monoclonal antibodies in sepsis.
    de Koning J; Westendorp RG
    Neth J Med; 1992 Apr; 40(3-4):215. PubMed ID: 1603215
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.
    McCloskey RV; Straube RC; Sanders C; Smith SM; Smith CR
    Ann Intern Med; 1994 Jul; 121(1):1-5. PubMed ID: 8198341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapies directed against endotoxin--has the time come?
    Quezado ZM; Hoffman WD
    West J Med; 1993 Apr; 158(4):424-5. PubMed ID: 8317138
    [No Abstract]   [Full Text] [Related]  

  • 20. BSAC, third combined British Scandinavian Hellenic Conference, May 1991: immunotherapy of infectious disease.
    Evans TJ; Cohen J
    J Antimicrob Chemother; 1992 May; 29(5):495-8. PubMed ID: 1624389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.